Fundraising Fox
Cambridge · Seed–Series B · 19 people tracked
Also known as QIMING U.S. VENTURES MANAGEMENT, LLC
Find your way into Qiming Venture Partners USA
Each arrow is one introduction. Sign up to fill in the first one.
Ask Anna French to introduce you to Gary Rieschel
You →Anna · together at Qiming Healthcare →Gary
Ask Jamie Chen to introduce you to Ryan Baker
You →Jamie · together at Qiming Venture Partners USA →Ryan
Ask Sam Okafor to introduce you to Mark McDade
You →Sam · together at Qiming Venture Partners USA →Mark
- Anna French5 people can intro you
- Gary Rieschel5 people can intro you
- Will McConnell5 people can intro you
Sign up to find every way you can get introduced to Qiming Venture Partners USA
- Your email: who you already know at Qiming Venture Partners USA, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Qiming Venture Partners USA team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
The firm positions itself as a hands-on partner to healthcare companies, bringing deep technical expertise, operational experience, an expansive network, and a global mindset. Having built and shaped companies from both the founder and investor sides, the team supports portfolio companies throughout their lifecycle — from early concept through regulatory approval and commercialization — with the aim of making a lasting impact in healthcare.
Source: firm website, verified Oct 1, 2026.
Team · 19 people
from the firm's website & curated & public directoriesWhat they invest in
from 17 of 28 portfolio companiesBiotech ×12Healthtech ×9Digital Health ×5AI & Machine Learning ×3Medical Devices ×3Data & Infrastructure ×2Enterprise Software ×2Deep Tech ×1
HQs:United States×17
Who they back
founder profiles across 9 portfolio companiesFounding team size:solo founder×42 founders×43 founders×1
Investments · 28 tracked
founders shown can be your intro pathBy year:2025 · 42021 · 12020 · 12019 · 12017 · 18 dated
Jasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases.
BiotechHealthtechRedwood City, US
Judith Shizuru(Director)Herb Cross(Executive Officer)inJeet Mahal(Executive Officer, Director)inPatrick Crutcher(Director)Svetlana Lucas(Director)Wenru Song(Executive Officer)
Co-investorsAvego BioScience CapitalTSVCAbingworthIkarian Capital
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
BoardJean-Francois Formela(Director)in
Co-investorsAtlas VentureMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaRock Springs CapitalTaiwania Capital+1 more
Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.
BiotechHealthtechSeattle, US
Andrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)
BoardIrena Melnikova(Executive Officer)Anna French(Director)Robert Glassman(Director)John Hamer(Director)in
Co-investorsMPM BioImpactDCVC BioSoftBank GroupK2 HealthVenturesSoftBank Vision FundDCVC (Data Collective)
BiotechNewton, US
Katharine Yen(Executive Officer, Director)Kate Yen(Founder)inChristopher Guiffre(Executive Officer)
BoardAlon Lazarus(Director)Anna French(Director)inAlexandra Cantley(Director)in
Co-investorsDCVC (Data Collective)Apollo Health VenturesDCVC BioPolaris Partners
Boulder provides medication-assisted treatment for addiction through licensed specialists who prescribe buprenorphine, supported by dedicated care teams offering medical care, peer recovery coaching, and care coordination accessible via a digital platform.
Digital HealthHealthtechMental HealthBoulder, US
Stephanie Papes(Cofounder)
Co-investorsAdvance Venture PartnersAlumni VenturesFirst Round CapitalGreycroftLaerdal Million Lives FundTusk Venture Partners+3 more
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsSlater Technology FundAccess IndustriesAtlas VentureClal Biotechnology IndustriesCowen Healthcare InvestmentsQiming Venture Partners
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Greg Lazar, Ph.D.(Co-Founder and Chief Scientific Officer)Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)inKarim Dabbagh, Ph.D.(Chief Executive Officer, Board Member)in
Co-investorsQiming Venture PartnersSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming Healthcare
Fuze Health operates a unified digital healthcare platform spanning digital pharmacy (FuzeRx), clinical services such as diagnostics, screening and genetics (Fuze Services), and data and technology tools (Fuze Technologies).
AI & Machine LearningDigital HealthHealthtechSaaS
Co-investorsFJ LabsHLM Investment PartnersIllumina VenturesK2 HealthVenturesOlive Tree CapitalSoftBank Vision Fund+2 more
Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Co-investorsBay City CapitalChiesi VenturesPappas CapitalSolasta VenturesCowen Healthcare InvestmentsEcoR1 Capital+1 more
MyHealthTeam builds social networks for people diagnosed with chronic health conditions, connecting patients so they can share experiences and manage their health.
Digital HealthHealthtechSocialSan Francisco, US
Eric Peacock(Co-Founder and CEO)inMary Ray(Co-Founder and COO)inElizabeth Luce(EVP Partnerships and Partner Operations)inTomas Melian(SVP Marketing)inDavid Wygant(SVP Product)inDante Gaudio(EVP of Community)in
Co-investors500 GlobalEvolution VC PartnersSand Hill AngelsThe Westly GroupTSVCAdams Street Partners+2 more
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD).
BiotechHealthtechBerkeley, US
Jeremy Reiter(Scientific Co-Founder)Markus Delling(Scientific Co-Founder)Thomas Gustafson(Executive Officer)inEmily Conley(Executive Officer, Director)in
BoardEvan Caplan(Director)inCharlotte McKee(Director)
Co-investors5AM VenturesOrbiMedAtlas Venture
Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US
Adam Branch(Executive Officer, Director, Promoter)in
BoardHarrison Touati(Director)Jon Galitzer(Director)
Co-investorsKoch Disruptive TechnologiesLionBirdMitsui Global InvestmentAlleyCorpGaingelsTiger Global Management+1 more
__Twitter.png)
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US
Dr. Ittai DayaninIttai Dayan(Dr.)inYuval Baror(Founder)inChristopher Laws(Executive Officer)
BoardEdward Michael(Director)inIvneet Bhullar(Director)in
Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdMitsui Global InvestmentAlley Robotics Ventures+2 more
Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye.
BiotechDigital HealthHealthtechLongevityMedical DevicesWarren, US
HENRIC BJARKE(Chief Executive Officer)in
Co-investorsAdBio partnersF-Prime CapitalSofinnova Partners
WindMIL Therapeutics is a clinical-stage biotechnology company developing cell-based immuno-oncology therapies using marrow-infiltrating lymphocytes (MILs), T cells extracted from a cancer patient's bone marrow that are activated and expanded before being returned to the patient.
BiotechMedical DevicesPrinceton, US
Ivan Borrello(Founder)Kimberly Noonan(Founder)in
BoardBrian Halak(Executive Officer, Director)
Co-investorsQiming Healthcare
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Amphivena TherapeuticsArmo BiosciencesCardialenEmpiricoevermoreIcosavaxMadaketTalaris TherapeuticsTwine HealthUmojaZappRx
Exits · 3
2 IPOs · 1 acquisitionsJasper TherapeuticsNASDAQ: JSPRKorro BioNASDAQ: KRROCadenttxacq. by Novartis
Portfolio news
latest coverage across their companiesTenpoint Therapeutics · tenpointtherapeutics.com · Apr 6, 2026
Frequently asked questions
- How many investments has Qiming Venture Partners USA made?
- Qiming Venture Partners USA has 28 tracked investments, 3 of which have exited, including 4 dated in the last 24 months.
- What stage does Qiming Venture Partners USA invest at?
- Qiming Venture Partners USA invests at the Seed, Series A, Series B stages.
- What sectors does Qiming Venture Partners USA focus on?
- Qiming Venture Partners USA focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Qiming Venture Partners USA located?
- Qiming Venture Partners USA is headquartered in Cambridge, US.
- Does Qiming Venture Partners USA lead rounds?
- Qiming Venture Partners USA typically participates in rounds rather than leading them.
- Who does Qiming Venture Partners USA co-invest with?
- Qiming Venture Partners USA most often shares deals with TSVC, DCVC (Data Collective), First Round Capital, among 35 tracked co-investors.
Co-investors · 7
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Techstars is a global startup accelerator and early-stage investor that funds and mentors ambitious founders, providing $220K in capital, a three-month program, and access to a worldwide network of mentors, investors, and corporate partners.
RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.
1955 Capital is an early-stage, thesis-driven venture firm founded in 2016 that invests in companies commercializing foundational science across biology, materials, energy, and computation.
Firms observed investing alongside Qiming Venture Partners USA, from public investor directories. Shared companies are the overlap with Qiming Venture Partners USA's recorded portfolio.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
EQT Life Sciences (formerly LSP) is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally.
ARTIS Ventures is a venture capital firm investing in breakthrough companies at the convergence of technology and biology, with a focus on healthcare and life sciences ('TechBio'). It backs founders across biotech, therapeutics, digital health, and frontier technologies.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.